… and bone marrow metastases remains unsatisfactory. We present the clinical data of 12
patients with lung adenocarcinoma and overt bone marrow metastases proven by bone marrow …

… influence of metastatic lesions were not elucidated in patients with lung cancer harboring …
277 patients diagnosed with stage IV lung adenocarcinoma. Studied were 246 patients with …

… Lung adenocarcinoma (ADC) is the main cause of death related to lung cancer. The aim of
this … for overall survival (OS) in patients with stage IV lung ADC in real-world clinical practice. …

… and prognosis of patients with lung adenocarcinoma of 2.0 cm or less in diameter. … A
total of 103 pN0 disease patients with peripheral lung adenocarcinomas of 2.0 cm or less …

… rate has been reported to be 43% (58 of 136 patients) in one … metastasis rate in lung
adenocarcinoma patients and the limited efficacy of PET or PET/CT for detecting brain metastasis, …

… erlotinib for patients with brain metastases from lung adenocarcinoma. Eligible participants
were chemotherapy-naive patients with brain metastases of lung adenocarcinoma and …

… and organ sites of metastasis in resected lung adenocarcinoma. The clinicopathological
characteristics of 748 patients of resected lung adenocarcinoma at Taipei Veterans General …

… The presence of organ metastases is a major factor for unfavorable prognosis in lung
adenocarcinoma (LADC). However, the influence of primary tumor location on metastatic sites and …

… did report lymph node metastasis in these cancers … patients (18 of 273) with stage T1A lung
adenocarcinoma had lymph node metastasis, and we therefore consider that these patients …

… ) lung … of lung adenocarcinoma patients with brain metastases. Experimental Design: This
was a retrospective analysis of 63 patients with brain metastases from lung adenocarcinoma …